We describe the MR spectroscopy findings in three patients with Pelizaeus-Merzbacker disease, a rare leukodystrophy associated with mutations of the PLP gene on chromosome X. The patients studied had different PLP gene mutations and presented different metabolic patterns, indicating a different phenotypic expression of mutations of the same gene.
L'imaging di Risonanza Magnetica Spettroscopica del protone nella malattia di Pelizaeus-Merzbacher Correlazioni con i diversi genotipi Background Pelizaeus-Merzbacher disease (PMD) is a rare leukodystrophy associated with mutations of the proteolipid protein (PLP) gene on the X-chromosome. The phenotypic expression ranges from mild paraplegia and ataxia to severe motor and cognitive impairment and early death.
A number of publications have reported MR Spectroscopic (MRS) changes in PMD patients. However, these findings are variable and the association of the gene defect with distinct MRS patterns is still unknown. Proton MRSI was performed in three patients with different PLP muta-tions and 5 age matched healthy controls, to determine possible associations between genotypes and specific metabolite patters.
Material and Methods
MR performed at 1.5 T: Axial PD, T 1 and T 2 weighted sequences. Multi-slice Proton MRSI: Slice thickness/gap, 15/2.5 mm, 24 cm FOV, 32 x 32 matrix, 0.8 cm 3 nominal voxel size, TR/TE 2300/272 msec, CHESS water suppression/ outer volume lipid suppression. Methabolic images (choline (Cho), creatine (Cr), N-acetyl aspartate (NAA) and lactate (Lac)) were created from integrated peak areas, interpolated to 256 x 256 Gaussian curve-fitting. Peak and ratios were determined in 4 voxels from each of the following regions: frontal white matter (WM) voxels, corticospinal-frontopontine tracts (projectional fibers), parieto-occipital WM, and 4 calcarinal gay matte voxels. Mean ratios of different regions were calculated.
Patient 1: 2.5 year old boy with severe hypotonia, nystagmus and cognitive and language delay. PLP gene analyses revealed a Lys150Asn mutation. MR imaging demonstrated diffuse T2 signal elevation throughout the centrum semiovale. Compared to age matched controls, proton MRSI suggested a decrease in NAA and an elevation of choline and creatine especially in the parieto-occipital white matter.
Patient 2: 3.5 year old boy with nystagmus, stable spastic ataxia, but normal and language development. Tha "Rumpshaker" mutation of pLP gene was detected in this patient. T2 weighted images demonstrated signal elevation limited to parieto-occipital deep white matter. Proton MRSI demonstrated an elevated choline in the T2 hyperintense region compared to the 2 age matched controls.
Patient 3: 7.5 old boy with mild paraplegia, ataxia and nystagmus, mildly impaired language ability but otherwise normal cognitive development. The PLP gene analysis elevated choline or creatine. Histological brain analysis of animals carrying the same PLP gene mutations has shown evidence of axonal damage, gliosis, and variable degree of demyelination. Our MRSI findings are in accordance with these histological findings. MRSI findings in PMD indicate a variability in the phenotypic expression of PLP mutations. demonstrated a Val165Gly mutation. T2 weighted images showed mild signal elevation in centrum semiovale. Proton MRSI suggested a reduced NAA in the hyperintense region and an elevation of creatine in the parieto-occipital white matter.
Discussion
Different metabolic patterns were detected in PMD patients with different clinical phenotypes and genotypes.
The Lys150Asn mutation manifested as an early onset disease with severely reduced NAA indicative of axonal degeneration, and also an increase of choline and creatine suggestive of demyelination and gliosis. The other two genotypes also demonstrated F. Pizzini, M.D. The Kennedy Krieger Institute and the Johns Hopkins Medical Institutions, Baltimore, MD. Departement of Neuroradiology University Hospital Verona; Italy
